DA Davidson raised the firm's price target on Nature's Sunshine to $33 from $23 and keeps a Buy rating on the shares. The company's beat and raise trend continues with Q4 results comfortably above consensus forecasts, and the firm sees further upward revisions as results underscore the extent to which the company's portfolio is under-penetrated across key markets, the analyst tells investors in a research note.
